新闻

Hyphens Pharma: To Develop & Commercialise Byfavo Procedural Sedation Drug In Singapore.

17 May 2023 17:23

Hyphens Pharma International Limited's subsidiary, Hyphens Pharma Pte. Ltd., has signed an exclusive sub-license and supply agreement with Hana Pharm Co., Ltd. to develop and commercialise Byfavo 20mg (remimazolam besylate 20mg) in Singapore...

Attachments:

• Hyphens_-_BYFAVO.pdf

Source: ShareInvestor Express